Plus Therapeutics, Inc. (NASDAQ: PSTV) has announced that its board of directors has approved a share repurchase program with authorization to repurchase up to USD 2 Million of the company’s outstanding common stock. The company plans to fund any share repurchases with available cash. “This share repurchase program reflects our continued confidence in our long-term …
Plus Therapeutics Reports Share Repurchase Program Read More »
CVS Health (NYSE: CVS) reported better-than-expected second-quarter results on Wednesday and consequently raised its earnings outlook for the year. The company’s shares rose approximately 5% upon the news. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” assets=”CVS” api=”yf”] [stock_market_widget type=”chart” template=”basic” color=”orange” assets=”CVS” range=”1mo” interval=”1d” axes=”true” cursor=”true” api=”yf” style=”width: 100%; height: 300px;”] The health-care company reported earnings of USD2.40 …
CVS Health (NYSE: CVS) reported first-quarter earnings that topped Wall Street expectations and ultimately raised its guidance for the year as demand for prescriptions rose and Covid vaccines and testing declined. The company’s shares rose over 1% during early morning trading. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” assets=”CVS” api=”yf”] [stock_market_widget type=”chart” template=”basic” color=”orange” assets=”CVS” range=”1mo” interval=”1d” axes=”true” …
CVS Increases 2022 Forecast Following First-Quarter Earnings Read More »
Pfizer (NYSE: PFE) is set to provide up to 4 million doses of its Covid-19 pill, Paxlovid, to low and middle-income countries amid an agreement with Unicef, the global relief organization. The pledge accounts for a little more than 3% of the company’s estimated yearly production of 120 million Paxlovid courses. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” …
Pfizer to Supply 4 Million Paxlovid Doses to UNICEF Read More »
Moderna (NASDAQ: MRNA) announced Thursday that it is seeking the US Food and Drug Administration’s authorization for a second Covid-19 booster shot for people over the age of 18. Amid a surge in Covid cases across the globe, many fear another wave of the pandemic. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” assets=”MRNA” api=”yf”] [stock_market_widget type=”chart” template=”basic” color=”orange” …
Moderna Requests Emergency Use for Second Covid Booster Shot Read More »
Moderna (NASDAQ: MRNA) announced Monday that it has established a memorandum of understanding with Kenya to build a covid vaccine manufacturing facility in Africa. The company is building the mRNA plant in Africa with the intention of producing a maximum of 500 million doses of vaccines per year. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” assets=”MRNA” api=”yf”] [stock_market_widget …
Unilever PLC (NYSE: UL), has opted to cut 1,500 management jobs worldwide as the company faces backlash from shareholders to boost growth. The change comes as the company shifts to a new organizational model that’s been in the works for the last couple of years. The firm currently employs over 149,000 people worldwide. [stock_market_widget type=”inline-label” …
Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has appointed Mr. Valentino Smith, MBA as Vice President of Marketing. Mr. Smith brings over ten years of marketing experience to Todos, including brick & mortar and digital marketing for consumer packaged goods, healthcare services & information, over-the-counter …
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Ocuphire Pharma, Inc. Announces Enrollment of First Patients in the MIRA-3 Phase 3 pivotal trial” Ocuphire Pharma, Inc. (NASDAQ: OCUP) surged over 44% in premarket trading after the company announced that the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial. …
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Dicerna Pharmaceuticals, Inc. Enters into a Definitive Agreement to be acquired by Novo Nordisk for USD3.3 Billion” Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) surged over 78% in premarket trading after Novo Nordisk entered into a definitive agreement to acquire the company for roughly 3.3 billion …
“The Buzz” Show: Dicerna Pharmaceuticals (NASDAQ: DRNA) Acquisition by Novo Nordisk Read More »
